Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

BMO Capital Maintains Market Perform Rating on Stem Inc Lowers Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On February 29, 2024, analyst Ameet Thakkar of BMO Capital decided to maintain a Market Perform rating on Stem (NYSE: STEM) but lowered the price target to $3.25 from $4. Thakkar, who specializes in the Utilities sector and has a success rate of 31.91%, made this adjustment after previously reaffirming a Hold rating on Stem Inc (STEM) with a price target of $6.5. This decision marks another occasion where BMO Capital has provided a Hold rating and price target for Stem Inc (STEM).

STEM Stock Plummets on February 29, 2024: Trading Near 52-Week Low

On February 29, 2024, STEM stock experienced a decline in its performance, trading near the bottom of its 52-week range and below its 200-day simple moving average. The price of STEM shares decreased by $0.06, representing a 2.20% drop from the previous market close. The stock opened at $2.51, which was $0.22 lower than its previous closing price.

STEM Stock Performance Analysis: Revenue Soars While Net Income Declines

On February 29, 2024, STEM stock had a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $362.98 million for the past year, which represented a significant increase of 184.98% compared to the previous year. Additionally, the total revenue for the third quarter of the year was $133.74 million, showing a 43.89% increase from the previous quarter.

However, despite the impressive revenue growth, STEM reported a net income of -$124.05 million for the past year, which was a decrease of 22.57% compared to the previous year. The net income for the third quarter was even lower at -$77.07 million, representing a significant decrease of 503.05% from the previous quarter.

Furthermore, the earnings per share (EPS) for STEM stock were reported at -$0.81 for the past year, showing a modest increase of 15.67% compared to the previous year. However, the EPS for the third quarter was -$0.49, indicating a sharp decline of 92.6% from the previous quarter.

Overall, the financial performance of STEM stock on February 29, 2024, reflected a mixed picture. Investors may want to closely monitor the company’s financial health and future outlook before making any investment decisions.

Tags: STEM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Stock Bull Market

Analysts Raise Price Targets for TJX Companies Following Strong Quarterly Report

Finance_ People trading stocks

Piper Sandler Downgrades Mosaic Stock Slashes Price Target

Real Estate Investment Trading online

NexPoint Real Estate Finance Projections for 1Q 2024

Recommended

TMUS stock news

Upstart Holdings Inc Faces Stock Price Decline Despite Exceeding Expectations

2 years ago
Finance_ Investing in stocks

BMO Capital Analyst Upgrades Price Target for WR Berkley NYSEWRB

2 years ago
Meta Stock

Meta’s High-Stakes Bet: Smart Glasses Launch Amid Economic Uncertainty

5 days ago

Anticipating Cara Therapeuticss Earnings Report What Investors Need to Know

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Leadership Shakeup Sparks Investor Concerns at Hims & Hers

Nio’s Record Quarter Signals Potential Turnaround

Navitas Semiconductor Faces Investor Anxiety Following Major Insider Transactions

A $400 Million Bet: Brown-Forman’s Boardroom Gamble

IonQ Shares Surge on Strategic Moves and Quantum Networking Breakthrough

Regulatory Shift Sends Shockwaves Through Fannie Mae

Trending

Walgreens Boots Alliance Stock
Healthcare

Pharmacy Sector Upheaval Creates Opening for Walgreens

by Dieter Jaworski
October 5, 2025
0

A dramatic realignment is underway in the U.S. pharmacy retail landscape. The permanent closure of all remaining...

Zuora Stock

Zuora Concludes Public Market Chapter with $1.7 Billion Acquisition

October 5, 2025
Iovance Biotherapeutics Stock

Iovance Shares Surge Amid Divergent Analyst Views

October 5, 2025
Hims & Hers Health Registered (A) Stock

Leadership Shakeup Sparks Investor Concerns at Hims & Hers

October 5, 2025
Nio Stock

Nio’s Record Quarter Signals Potential Turnaround

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pharmacy Sector Upheaval Creates Opening for Walgreens
  • Zuora Concludes Public Market Chapter with $1.7 Billion Acquisition
  • Iovance Shares Surge Amid Divergent Analyst Views

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com